Radiotherapy increases the levels of immune checkpoints (PD-1, CTLA-4) locally in the tumor by enhancing the activation and infiltration of immune cells into the TME and the level of PD-L1 expression on the surface of tumor cells (20). Here, CTLA4 is linked to neoplasm.